 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «123456789101112» |
- || alendronate / Generic mfg.
New P2/3 trial: Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis (clinicaltrials.gov) - Aug 7, 2015
P2/3, N=90, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- || atorvastatin / Generic mfg., alendronate / Generic mfg.
New P2/3 trial: Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment (clinicaltrials.gov) - Aug 5, 2015
P2/3, N=120, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- alendronate / Generic mfg.
New P4 trial: SANSPET: Sodium Alendronate in Non Surgical Periodontal Therapy (clinicaltrials.gov) - Jun 12, 2015
P4, N=32, Completed, Sponsor: Federal University of Minas Gerais
- alendronate / Generic mfg.
Trial primary completion date: EDGE: Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study (clinicaltrials.gov) - Jun 11, 2015
P4, N=36, Recruiting, Sponsor: University of Alabama at Birmingham
Trial primary completion date: May 2015 --> Oct 2015
- || metformin / Generic mfg., alendronate / Generic mfg.
New P2/3 trial: Alendronate Compared to Metformin in Chronic Periodontitis (clinicaltrials.gov) - Jun 3, 2015
P2/3, N=108, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- || atorvastatin / Generic mfg., alendronate / Generic mfg.
New P2/3 trial: Comparison of Alendronate With Atorvastatin in Chronic Periodontitis (clinicaltrials.gov) - May 28, 2015
P2/3, N=104, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- ||| alendronate / Generic mfg.
New trial, Video: Effect of a Tablet-administered Educational Video on Patients´ Knowledge on Osteoporosis and Treatment (clinicaltrials.gov) - May 15, 2015
P=N/A, N=67, Completed, Sponsor: University of Southern Denmark
- alendronate / Generic mfg., cinacalcet HCl / Generic mfg.
New trial: Renal Osteodystrophy: An Individual Management Approach (clinicaltrials.gov) - May 12, 2015
P=N/A, N=120, Not yet recruiting, Sponsor: Hartmut Malluche, MD
- alendronate / Generic mfg.
Trial primary completion date: BOCOMEDEN: Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=280, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Trial primary completion date: May 2015 --> Oct 2015 Trial primary completion date: Sep 2015 --> Jun 2016
- cinacalcet HCl / Generic mfg.
New P4 trial: CA-PHP: Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism (clinicaltrials.gov) - Apr 15, 2015
P4, N=22, Completed, Sponsor: Istituto Auxologico Italiano
- ||||| alendronate / Generic mfg.
New P4 trial: FACT: The Forteo Alendronate Comparator Trial (clinicaltrials.gov) - Apr 14, 2015
P4, N=203, Completed, Sponsor: Eli Lilly and Company
- ||||| Evenity (romosozumab) / Astellas, Amgen, UCB
Enrollment closed: ARCH: Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis (clinicaltrials.gov) - Apr 10, 2015
P3, N=4094, Active, not recruiting, Sponsor: Amgen
Trial primary completion date: Sep 2015 --> Jun 2016 Recruiting --> Active, not recruiting
- alendronate / Generic mfg.
Trial completion: Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis (clinicaltrials.gov) - Mar 25, 2015
P=N/A, N=60, Completed, Sponsor: University of North Carolina
Recruiting --> Active, not recruiting Recruiting --> Completed
- alendronate / Generic mfg.
Trial completion: Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease (clinicaltrials.gov) - Mar 25, 2015
P2, N=82, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Recruiting --> Completed Recruiting --> Completed
- ||||| risedronate / Generic mfg., alendronate / Generic mfg.
Enrollment change, Trial primary completion date: A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) (clinicaltrials.gov) - Mar 2, 2015
P3, N=936, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed N=760 --> 936 | Trial primary completion date: Sep 2005 --> Oct 2004
- ||||| alendronate / Generic mfg.
New P4 trial: Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment (clinicaltrials.gov) - Feb 26, 2015
P4, N=120, Recruiting, Sponsor: Mahidol University
- alendronate / Generic mfg.
Enrollment closed: The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults (clinicaltrials.gov) - Feb 20, 2015
P1, N=20, Active, not recruiting, Sponsor: Massachusetts General Hospital
N=760 --> 936 | Trial primary completion date: Sep 2005 --> Oct 2004 Recruiting --> Active, not recruiting
- |||| Evenity (romosozumab) / Astellas, Amgen, UCB
Trial primary completion date: ARCH: Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis (clinicaltrials.gov) - Jan 30, 2015
P3, N=4000, Recruiting, Sponsor: Amgen
Recruiting --> Active, not recruiting Trial primary completion date: Jan 2017 --> Apr 2017
- ||||| Tymlos (abaloparatide) / Radius, Teijin
Enrollment closed: ACTIVExtend: Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis (clinicaltrials.gov) - Jan 15, 2015
P3, N=1200, Active, not recruiting, Sponsor: Radius Health, Inc.
Trial primary completion date: Jan 2017 --> Apr 2017 Recruiting --> Active, not recruiting
- | alendronate / Generic mfg.
Enrollment open: Alendronate to Prevent Loss of Bronchoprotection in Asthma (clinicaltrials.gov) - Jan 13, 2015
P2/3, N=76, Recruiting, Sponsor: Milton S. Hershey Medical Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | alendronate / Generic mfg.
New P4 trial: APART: Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss (clinicaltrials.gov) - Dec 22, 2014
P4, N=80, Not yet recruiting, Sponsor: University College Dublin
- Clinical: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=206, Not yet recruiting, Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- | alendronate / Generic mfg.
New P4 trial: Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta (clinicaltrials.gov) - Dec 1, 2014
P4, N=99, Completed, Sponsor: Peking Union Medical College Hospital
- alendronate / Generic mfg.
Trial completion, Trial primary completion date: Stem Cell Recruitment in Osteoporosis Therapy (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=46, Completed, Sponsor: Suzanne Jan de Beur, MD
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Aug 2016 --> Aug 2014
- alendronate / Generic mfg.
Enrollment open, Trial primary completion date: The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults (clinicaltrials.gov) - Oct 24, 2014
P1, N=20, Recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | Trial primary completion date: Aug 2016 --> Aug 2014 Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2015 --> Feb 2016
- alendronate / Generic mfg.
Trial primary completion date: Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) (clinicaltrials.gov) - Oct 2, 2014
P4, N=16, Active, not recruiting, Sponsor: Göteborg University
Not yet recruiting --> Recruiting | Trial primary completion date: Feb 2015 --> Feb 2016 Trial primary completion date: Dec 2013 --> Jul 2015
- Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion, Trial initiation date, Trial primary completion date: RA Denosumab on Bone Microstructure Study (clinicaltrials.gov) - Sep 11, 2014
P4, N=40, Completed, Sponsor: Chinese University of Hong Kong
Trial primary completion date: Dec 2013 --> Jul 2015 Not yet recruiting --> Completed | Initiation date: Sep 2013 --> Dec 2012 | Trial primary completion date: Sep 2014 --> Jun 2014
- || alendronate / Generic mfg.
New P2/3 trial: Alendronate to Prevent Loss of Bronchoprotection in Asthma (clinicaltrials.gov) - Sep 4, 2014
P2/3, N=76, Not yet recruiting, Sponsor: Milton S. Hershey Medical Center
- alendronate / Generic mfg.
New P2 trial: Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide (clinicaltrials.gov) - Jul 21, 2014
P2, N=30, Enrolling by invitation, Sponsor: Northwestern University
- alendronate / Generic mfg.
New P2 trial: 1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers (clinicaltrials.gov) - Jun 22, 2014
P2, N=46, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- alendronate / Generic mfg.
Enrollment open: EDGE: Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study (clinicaltrials.gov) - May 22, 2014
P4, N=36, Recruiting, Sponsor: University of Alabama at Birmingham
Not yet recruiting --> Completed | Initiation date: Sep 2013 --> Dec 2012 | Trial primary completion date: Sep 2014 --> Jun 2014 Not yet recruiting --> Recruiting
- alendronate / Generic mfg.
New P4 trial: EDGE: Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study (clinicaltrials.gov) - May 13, 2014
P4, N=36, Not yet recruiting, Sponsor: University of Alabama at Birmingham
- || Evenity (romosozumab) / Astellas, Amgen, UCB
P2 data, Trial completion date: Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density (clinicaltrials.gov) - May 8, 2014
P2, N=419, Active, not recruiting, Sponsor: Amgen
Not yet recruiting --> Recruiting Trial completion date: Mar 2014 --> Apr 2016
- ketoconazole / Generic mfg., alendronate / Generic mfg.
Trial termination, Metastases: Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - Apr 20, 2014
P2, N=0, Terminated, Sponsor: National Cancer Institute (NCI)
Trial completion date: Mar 2014 --> Apr 2016 Active, not recruiting --> Terminated
- alendronate / Generic mfg.
Enrollment closed: Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents (clinicaltrials.gov) - Apr 7, 2014
P2, N=51, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Terminated Recruiting --> Active, not recruiting
- | alendronate / Generic mfg.
Trial completion: Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) (clinicaltrials.gov) - Feb 22, 2014
P3, N=140, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion: The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients (clinicaltrials.gov) - Feb 22, 2014
P2, N=80, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| alendronate / Generic mfg.
Trial completion: Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis (clinicaltrials.gov) - Feb 22, 2014
P3, N=428, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Active, not recruiting --> Completed
- raloxifene hydrochloride / Generic mfg., alendronate / Generic mfg.
Trial completion: EVA: Evista Alendronate Comparison (clinicaltrials.gov) - Feb 22, 2014
P4, N=0, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Terminated --> Completed
- |||| risedronate / Generic mfg., alendronate / Generic mfg.
Trial completion: OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women (clinicaltrials.gov) - Feb 22, 2014
P4, N=290, Completed, Sponsor: Sanofi
Terminated --> Completed No longer recruiting --> Completed
- |||| raloxifene hydrochloride / Generic mfg., alendronate / Generic mfg.
Trial completion: Effects of Teriparatide in Postmenopausal Women With Osteoporosis (clinicaltrials.gov) - Feb 22, 2014
P4, N=200, Completed, Sponsor: Eli Lilly and Company
No longer recruiting --> Completed No longer recruiting --> Completed
- alendronate / Generic mfg.
Trial completion: Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis (clinicaltrials.gov) - Feb 19, 2014
P2, N=10, Completed, Sponsor: Medical University of South Carolina
No longer recruiting --> Completed Not yet recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion: PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis (clinicaltrials.gov) - Feb 19, 2014
P2, N=238, Completed, Sponsor: Dennis Black
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion: Effects of Parathyroid Hormone in Men With Osteoporosis (clinicaltrials.gov) - Feb 19, 2014
P3, N=81, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed No longer recruiting --> Completed
- | alendronate / Generic mfg.
Trial completion: Alendronate and/or Parathyroid Hormone for Osteoporosis (clinicaltrials.gov) - Feb 19, 2014
P2, N=176, Completed, Sponsor: Massachusetts General Hospital
No longer recruiting --> Completed Active, not recruiting --> Completed
- alendronate / Generic mfg.
New P1 trial: The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults (clinicaltrials.gov) - Feb 5, 2014
P1, N=20, Not yet recruiting, Sponsor: Massachusetts General Hospital
- ||||| alendronate / Generic mfg.
Trial initiation date: FACT: A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) (clinicaltrials.gov) - Dec 1, 2013
P3, N=1053, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Initiation date: Feb 2002 --> Sep 2002
- ||||||| Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion, Adherence: Denosumab Adherence Preference Satisfaction Study (clinicaltrials.gov) - Nov 18, 2013
P3, N=250, Completed, Sponsor: Amgen
Initiation date: Feb 2002 --> Sep 2002 Active, not recruiting --> Completed
- Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment open: Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption (clinicaltrials.gov) - Oct 21, 2013
P4, N=40, Recruiting, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Evenity (romosozumab-aqqg) / Astellas, Amgen, UCB
Trial completion: Transition From Alendronate to Romosozumab (AMG 785) (clinicaltrials.gov) - Oct 9, 2013
P1, N=60, Completed, Sponsor: Amgen
Not yet recruiting --> Recruiting Active, not recruiting --> Completed